These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38670801)

  • 1. Unique Binding Sites of Uricosuric Agent Dotinurad for Selective Inhibition of Renal Uric Acid Reabsorptive Transporter URAT1.
    Fujita K; Isozumi N; Zhu Q; Matsubayashi M; Taniguchi T; Arakawa H; Shirasaka Y; Mori E; Tamai I
    J Pharmacol Exp Ther; 2024 Jun; 390(1):99-107. PubMed ID: 38670801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
    Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
    J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the Uricosuric Effect of Dotinurad by
    Fujita K; Zhu Q; Arakawa H; Shirasaka Y; Tamai I
    Drug Metab Dispos; 2023 Nov; 51(11):1527-1535. PubMed ID: 37643882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease.
    Yanai H; Adachi H; Hakoshima M; Iida S; Katsuyama H
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Reabsorptive Transport of Uric Acid Precursor Xanthine by URAT1 and GLUT9.
    Arakawa H; Amezawa N; Kawakatsu Y; Tamai I
    Biol Pharm Bull; 2020; 43(11):1792-1798. PubMed ID: 33132325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
    Ahn SO; Ohtomo S; Kiyokawa J; Nakagawa T; Yamane M; Lee KJ; Kim KH; Kim BH; Tanaka J; Kawabe Y; Horiba N
    J Pharmacol Exp Ther; 2016 Apr; 357(1):157-66. PubMed ID: 26907620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study.
    Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T
    Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):53-61. PubMed ID: 31792640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study.
    Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T
    Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):44-52. PubMed ID: 31754882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout.
    Tan PK; Liu S; Gunic E; Miner JN
    Sci Rep; 2017 Apr; 7(1):665. PubMed ID: 28386072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.
    Nakanishi T; Ohya K; Shimada S; Anzai N; Tamai I
    Nephrol Dial Transplant; 2013 Mar; 28(3):603-11. PubMed ID: 23291366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uricosuric Agents Affect Plasma and Kidney Concentration of Adefovir via Inhibition of Oat1 and Mrp2 in Rats.
    Motoki K; Taniguchi T; Ashizawa N; Sakai M; Chikamatsu N; Yamano K; Iwanaga T
    Biol Pharm Bull; 2023; 46(2):170-176. PubMed ID: 36724945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does whisky lower serum urate level?
    Lu Y; Nakanishi T; Fukazawa M; Tamai I
    Phytother Res; 2014 May; 28(5):788-90. PubMed ID: 24022993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label study of long-term administration of dotinurad in Japanese hyperuricemic patients with or without gout.
    Hosoya T; Fushimi M; Okui D; Sasaki T; Ohashi T
    Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):80-91. PubMed ID: 31875931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An LC-MS/MS- and hURAT1 cell-based approach for screening of uricosuric agents.
    Sun C; Zhang M; Zhao Y; Pang J; Peng Y; Zheng J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1159():122336. PubMed ID: 32905987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
    Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
    Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.
    Shin HJ; Takeda M; Enomoto A; Fujimura M; Miyazaki H; Anzai N; Endou H
    Nephrology (Carlton); 2011 Feb; 16(2):156-62. PubMed ID: 21272127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urate Transporter 1 Can Be a Therapeutic Target Molecule for Chronic Kidney Disease and Diabetic Kidney Disease: A Retrospective Longitudinal Study.
    Yanai H; Katsuyama H; Hakoshima M; Adachi H
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
    Iwanaga T; Kobayashi D; Hirayama M; Maeda T; Tamai I
    Drug Metab Dispos; 2005 Dec; 33(12):1791-5. PubMed ID: 16135657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor.
    Cai W; Wu J; Liu W; Xie Y; Liu Y; Zhang S; Xu W; Tang L; Wang J; Zhao G
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29382075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation method for uric acid uptake inhibition using primary human proximal tubule epithelial cells treated with insulin.
    Uda J; Ashizawa N; Iwanaga T
    Nucleosides Nucleotides Nucleic Acids; 2022; 41(8):724-735. PubMed ID: 35770496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.